Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Universiteit Utrecht Holding B.V. is currently managing 3 pending office actions within the Chemistry & Materials technology area. These matters are all concentrated within 1 distinct art unit, which indicates that the company's current patent office activity is focused in a single technical group. This concentration allows for a specialized prosecution approach within that specific art unit.
The portfolio's workload is distributed among 3 distinct examiners. This means that every pending office action is currently being reviewed by a different individual. CLAIRE A NORRIS is identified as the busiest examiner for this entity, currently overseeing 1 pending office action. Having distinct examiners for pending office actions suggests that the applicant is interacting with a variety of perspectives even within a single art unit.
The presence of pending office actions across distinct examiners requires the applicant to manage multiple simultaneous timelines. Because all activity is within the distinct art unit, the legal team can focus their efforts on the specific procedural nuances of that group while addressing the individual requirements of CLAIRE A NORRIS and the other examiners.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NORRIS, CLAIRE A | 1 | 65.8% | +28.0% |
| BRAZIN, JACQUELINE | 1 | 66.0% | +52.7% |
| RIETH, STEPHEN EDWARD | 1 | 45.8% | +32.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18764454 | Degradation of fluor containing substances by bioconversion | NORRIS, CLAIRE A | — |
| 18687429 | BIOREACTOR FOR PRODUCTION OF ORGANOIDS | BRAZIN, JACQUELINE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18036924 | SHRINKABLE HYDROGELS | RIETH, STEPHEN EDWARD | 9d overdue |
| 18764454 | Degradation of fluor containing substances by bioconversion | NORRIS, CLAIRE A | — |
| 18687429 | BIOREACTOR FOR PRODUCTION OF ORGANOIDS | BRAZIN, JACQUELINE | — |
| Art Unit | Apps |
|---|---|
| 1759 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18764454 | Degradation of fluor containing substances by bioconversion | NORRIS, CLAIRE A | — | §102§112 | Non-Final OA | — | Pending | Jul 05, 2024 |
| 18687429 | BIOREACTOR FOR PRODUCTION OF ORGANOIDS | BRAZIN, JACQUELINE | — | §102§103 | Non-Final OA | — | Pending | Feb 28, 2024 |
| 18036924 | SHRINKABLE HYDROGELS | RIETH, STEPHEN EDWARD | 1759 | §102 | Final Rejection | 9d overdue | Pending | May 15, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial